Management of gastroesophageal varices in cirrhotic patients: current status and future directions
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 3
Abstract
Bleeding from gastroesophageal varices (GEV) is a serious event in cirrhotic patients and can cause death. According to the explosión theory, progressive portal hypertension is the primary mechanism underlying variceal bleeding. There are two approaches for treating GEV: primary prophylaxis to manage bleeding or emergency treatment for bleeding followed by secondary prophylaxis. Treatment methods can be classified into two categories: 1) Those used to decrease portal pressure, such as medication (i.e., nonselective β-blockers), radiological intervention [transjugular intrahepatic portosystemic shunt (TIPS)] or a surgical approach (i.e., portacaval shunt), and 2) Those used to obstruct GEV, such as endoscopy [endoscopic variceal ligation (EVL), endoscopic injection sclerotherapy (EIS), and tissue adhesive injection] or radiological intervention [balloon-occluded retrograde transvenous obliteration (BRTO)]. Clinicians should choose a treatment method based on an understanding of its efficacy and limitations. Furthermore, elastography techniques and serum biomarkers are noninvasive methods for estimating portal pressure and may be helpful in managing GEV. The impact of these advances in cirrhosis therapy should be evaluated for their effectiveness in treating GEV.
Authors and Affiliations
Nobuyuki Toshikuni, Yoshitaka Takuma, Mikihiro Tsutsumi
Keywords
Related Articles
- EP ID EP78572
- DOI 10.5604/16652681.1198800
- Views 114
- Downloads 0
[b][/b]
Non alcoholic fatty liver disease
Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment
Epidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk....
Introductory message from the President of the Latin American Association or the Study of the Liver
Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation